Disclosed positions

Estimated from their latest filings — positions may have changed since

$17.4K

combined est. value

Stock	Shares	Price	Value	Weight	As of
ACRVAcrivon Therapeutics, Inc.	9,366	$1.86	$17.4K	100%	2026-05-18

ACRV

Acrivon Therapeutics, Inc.

$17.4K

9,366 sh

All filings on record

Every Form 4 transaction we track for this filer

all 1buys 0sells 0

Stock	Transaction	Date	~6mo later
ACRVAcrivon Therapeutics, Inc.	Grant — · 9,366 sh	2026-05-18	—

ACRVGrant

2026-05-18 · Acrivon Therapeutics, Inc.

9,366

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.